Справка
x
Поиск
Закладки
Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Дефицит 3-гидрокси-3-метилглутарил-КоА лиазы
Список литературы
Поставить закладку
Huang Z. et al. Newborn screening for 3-hydroxy-3-methylglutaric aciduria using direct analysis in real-time mass spectrometry // J Mass Spectrom. 2019. Vol. 54, № 2. P. 134–140.
Wysocki SJ, Hähnel R. 3-Hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a review. Journal of inherited metabolic disease. 1986 Sep;9(3):225-33.
dos Santos Mello M, Ribas GS, Wayhs CA, Hammerschmidt T, Guerreiro GB, Favenzani JL, Sitta Â, de Moura Coelho D, Wajner M, Vargas CR. Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Molecular and cellular biochemistry. 2015 Apr; 402:149-55.
Wysocki S.J., Hähnel R. 3-hydroxy-3-methylglutaric aciduria: Deficiency of 3-hydroxy-3-methylglutaryl coenzyme a lyase // Clinica Chimica Acta. 1976. Vol. 71, № 2. P. 349–351.
Holdar S, Rahbeeni Z, Ramzan K, Imtiaz F. Hepatic Manifestations of 3-Hydroxy-3-Methylglutaryl-Coenzyme-A Lyase Deficiency in Saudi Patients: Experience of a Tertiary Care Center. Journal of Pediatric Genetics. 2021 Jun;10(02):105-10.
Menao S. et al. Ten novel
HMGCL
mutations in 24 patients of different origin with 3-hydroxy-3-methyl-glutaric aciduria // Hum. Mutat. 2009. Vol. 30, № 3. P. E520–E529.
Alharby, Essa, et al. "Recurrent mutation in the HMGCL gene in a family segregating HMG-CoA lyase deficiency." International Journal of Genetics and Molecular Biology 8.3 (2016): 11-17.
Wajner M, de Moura Coelho D, Ingrassia R, de Oliveira AB, Busanello EN, Raymond K, Pires RF, de Souza CF, Giugliani R, Vargas CR. Selective screening for organic acidemias by urine organic acid GC–MS analysis in Brazil: Fifteen-year experience. Clinica Chimica Acta. 2009 Feb 1;400(1-2):77-81.
Vargas CR, Sitta A, Schmitt G, Ferreira GC, Cardoso ML, Coelho D, Gibson KM, Wajner M. Incidence of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a lyase (HL) deficiency in Brazil, South America. Journal of Inherited Metabolic Disease: Official Journal of the Society for the Study of Inborn Errors of Metabolism. 2008 Dec; 31:511-5.
Pié J. et al. A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency // Biochemical Journal. 1997. Vol. 323, № 2. P. 329–335.
Puisac B, Teresa-Rodrigo ME, Arnedo M, Gil-Rodríguez MC, Pérez-Cerdá C, Ribes A, Pié Á, Bueno G, Gómez-Puertas P, Pié J. Analysis of aberrant splicing and nonsense-mediated decay of the stop codon mutations c. 109G> T and c. 504_505delCT in 7 patients with HMG-CoA lyase deficiency. Molecular Genetics and Metabolism. 2013 Apr 1;108(4):232-40.
Pié J. et al. Molecular genetics of HMG-CoA lyase deficiency // Molecular Genetics and Metabolism. 2007. Vol. 92, № 3. P. 198–209.
Grünert SC, Sass JO. 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: one disease - many faces [published correction appears in Orphanet J Rare Dis. 2022 Jan 10;17(1):16]. Orphanet J Rare Dis. 2020;15(1):48. Published 2020 Feb 14. doi:10.1186/s13023-020-1319-7.
Santosa D. et al. Favourable Outcome in Two Pregnancies in a Patient with 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency // JIMD Reports, Volume 37 / ed. Morava E. et al. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. Vol. 37. P. 1–5.
Fukao T. et al. Ketone body metabolism and its defects // J Inherit Metab Dis. 2014. Vol. 37, № 4. P. 541–551.
Magoulas P.L., El-Hattab A.W. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management // Orphanet J Rare Dis. 2012. Vol. 7, № 1. P. 68.
Alfadhel M. et al. HMG-CoA Lyase Deficiency: A Retrospective Study of 62 Saudi Patients // Front. Genet. 2022. Vol. 13. P. 880464.
Delgado CA, Guerreiro GB, Jacques CE, de Moura Coelho D, Sitta A, Manfredini V, Wajner M, Vargas CR. Prevention by l-carnitine of DNA damage induced by 3-hydroxy-3-methylglutaric and 3-methylglutaric acids and experimental evidence of lipid and DNA damage in patients with 3-hydroxy-3-methylglutaric aciduria. Archives of biochemistry and biophysics. 2019 Jun 15;668:16-22.
Grünert SC, Schlatter SM, Schmitt RN, et al. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients. Mol Genet Metab. 2017;121(3):206-215. doi:10.1016/j.ymgme.2017.05.014
Santarelli F. et al. A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency // Ital J Pediatr. 2013. Vol. 39, № 1. P. 33.
Bischof F. et al. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy: HMG Lyase Deficiency // Ann Neurol. 2004. Vol. 56, № 5.
Reimão S, Morgado C, Almeida IT, Silva M, Real HC, Campos J. 3‐Hydroxy‐3‐methylglutaryl‐coenzyme A lyase deficiency: Initial presentation in a young adult. Journal of Inherited Metabolic Disease: Official Journal of the Society for the Study of Inborn Errors of Metabolism. 2009 Dec;32:49-52.
Boutouchent N, Bourilhon J, Sudrié-Arnaud B, et al. An Atypical Case of Head Tremor and Extensive White Matter in an Adult Female Caused by 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency. Diagnostics (Basel). 2021;11(9):1561. Published 2021 Aug 28. doi:10.3390/diagnostics11091561.
Václavík J, Mádrová L, Kouřil Š, de Sousa J, Brumarová R, Janečková H, Jáčová J, Friedecký D, Knapková M, Kluijtmans LA, Grünert SC. A newborn screening approach to diagnose 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency. JIMD reports. 2020 Jul;54(1):79-86.
C Lee 1, F J Tsai, J Y Wu, C T Peng, C H Tsai, W L Hwu, T R Wang, D S Millington. 3-hydroxy-3-methylglutaric aciduria presenting with Reye like syndrome: report of one case. Vol. Acta Paediatr Taiwan.
Karcher C, Rousselot J M, Lefebvre E, Vidailhet M. [Hydroxy-methyl-glutaryl-coenzyme A lyase deficiency manifesting as Reye"s syndrome in a 3-year-old girl]
Pediatrie.
1993;48(05):385–387.
Leonard J V, Seakins J W, Griffin N K. beta-Hydroxy-beta-methyglutaricaciduria presenting as Reye"s syndrome
Lancet
19791(8117):680
Muroi J. et al. Cerebral infarction and pancreatitis: possible complications of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency // J Inherit Metab Dis. 2000. Vol. 23, № 6. P. 636–637.
Wilson WG, Cass MB, Søvik O, Gibson KM, Sweetman L. A child with acute pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. European journal of pediatrics. 1984 Sep;142:289-91.
Muñoz-Bonet JI, Ortega-Sánchez MD, León Guijarro JL. Management and long-term evolution of a patient with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. Italian Journal of Pediatrics. 2017 Dec;43(1):1-5.
Yýlmaz Y, Özdemir N, Ekinci G, Baykal T, Kocaman C. Corticospinal tract involvement in a patient with 3-HMG coenzyme A lyase deficiency. Pediatric neurology. 2006 Aug 1;35(2):139-41.
Hao X. et al. 3-Hydroxy-3-methylglutaric aciduria with bilateral basal ganglia lesion: A case report // Experimental and Therapeutic Medicine. 2016. Vol. 11, № 6. P. 2573–2576.
Lisson G. et al. CT findings in a case of deficiency of 3-hydroxy-3-methylglutaryl-CoA-lyase // Neuroradiology. 1981. Vol. 22, № 2. P. 99–101.
Gibson K.M. et al. Fatal cardiomyopathy associated with 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency // J of Inher Metab Disea. 1994. Vol. 17, № 3. P. 291–294.
Leung AA, Chan AK, Ezekowitz JA, Leung AK. A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency. Case Rep Med. 2009; 2009:183125. doi:10.1155/2009/183125.
Francois B, Bachmann C, Schutgens RB. Glucose metabolism in a child with 3‐hydroxy‐3‐methylglutaryl‐coenzyme a lyase deficiency. Journal of Inherited Metabolic Disease. 1981 Dec;4(1):163-4.
Baker PR. Pathophysiology of Inherited Metabolic Diseases. In Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University 2022 Jun 15 (pp. 33-43). Cham: Springer International Publishing.
Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffmann GF. Emergency management of inherited metabolic diseases. Journal of inherited metabolic disease. 2002 Nov;25(7):531-46.
del Pilar Chantada-Vázquez M, Bravo SB, Barbosa-Gouveia S, Alvarez JV, Couce ML. Proteomics in Inherited Metabolic Disorders. International Journal of Molecular Sciences. 2022 Dec 1;23(23):14744.
Huemer M, Muehl A, Wandl-Vergesslich K, Strobl W, Wanders RJ, Stoeckler-Ipsiroglu S. Stroke-like encephalopathy in an infant with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. European journal of pediatrics. 1998 Aug; 157:743-6.
Gibson KM, Lee CF, Kamali V, Johnston K, Beaudet AL, Craigen WJ, Powell BR, Schwartz R, Tsai MY, Tuchman M. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency as detected by radiochemical assay in cell extracts by thin-layer chromatography, and identification of three new cases. Clinical chemistry. 1990 Feb 1;36(2):297-303.
Pipitone A, Raval DB, Duis J, Vernon H, Martin R, Hamosh A, Valle D, Gunay‐Aygun M. The management of pregnancy and delivery in 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency. American journal of medical genetics Part A. 2016 Jun;170(6):1600-2.
Wajner, M. Neurological manifestations of organic acidurias. Nat Rev Neurol 15, 253–271 (2019). https://doi.org/10.1038/s41582-019-0161-9
Неонатальный скрининг: национальное руководство/ под ред. С.И. Куцева. — Москва: ГЭОТАР-Медиа, 2023. — 360 с. — (Серия «Национальные руководства»). — DOI:10.33029/9704-7737-3-NEO-2023-1-360.
Alliance G. Understanding genetics: a district of Columbia guide for patients and health professionals.
Yilmaz O, Kitchen S, Pinto A, Daly A, Gerrard A, Hoban R, Santra S, Sreekantam S, Frost K, Pigott A, MacDonald A. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: a case report and literature review. Nutrición Hospitalaria. 2018;35(1):237-44.
Dasouki M, Buchanan D, Mercer N, Gibson K M, Thoene J. 3-Hydroxy-3-methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction.
J Inherit Metab Dis.
1987;10(02):142–146.
Анисимова И.В. и др. Методические рекомендации «Метод получения сухого пятна крови на тест-бланк для проведения клинико-лабораторных исследований». 2022:34.
Lai V, Shahidi M, Chan A, Jain-Ghai S. First report of type 2 diabetes mellitus in an adult with 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. Endocrinol Diabetes Metab Case Rep. 2023;2023(1):22-0413. Published 2023 Mar 29. doi:10.1530/EDM-22-0413
Kelley RI, Cheatham JP, Clark BJ, et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr. 1991;119(5):738-747. doi:10.1016/s0022-3476(05)80289-6
Georg F. Hoffmann, Johannes Zschocke, William L. Nyhan. Inherited Metabolic Diseases: A Clinical Approach, Springer Science & Business Media, 2009
Для продолжения работы требуется
Registration
Предыдущая страница
Следующая страница
Table of contents
Список сокращений
Термины и определения
1. Краткая информация по заболеванию или состоянию (группы заболеваний или состояний)
+
2. Диагностика заболевания или состояния (группы заболеваний или состояний) медицинские показания и противопоказания к применению методов диагностики
+
3. Лечение, включая медикаментозную и немедикаментозную терапии, диетотерапию, обезболивание, медицинские показания и противопоказания к применению методов лечения
+
4. Медицинская реабилитация и санаторно-курортное лечение, медицинские показания и противопоказания к применению методов медицинской реабилитации, в том числе основанных на использовании природных лечебных факторов
5. Профилактика и диспансерное наблюдение, медицинские показания и противопоказания к применению методов профилактики
+
6. Организация оказания медицинской помощи
7. Дополнительная информация (в том числе факторы, влияющие на исход заболевания или состояния)
Критерии оценки качества медицинской помощи
Список литературы
Приложение А1. Состав рабочей группы по разработке и пересмотру клинических рекомендаций
Приложение А2. Методология разработки клинических рекомендаций
Приложение А3. Справочные материалы, включая соответствие показаний к применению и противопоказаний, способов применения и доз лекарственных препаратов, инструкции по применению лекарственного препарата
Приложение Б. Алгоритмы действий врача
Приложение В. Информация для пациента
Приложение Г1-ГN. Шкалы оценки, вопросники и другие оценочные инструменты состояния пациента, приведенные в клинических рекомендациях
Приложение Г1. Оценка моторного развития младенцев по шкале Альберта
Данный блок поддерживает скрол*